Shibin Zhou

40.8k total citations · 7 hit papers
66 papers, 14.9k citations indexed

About

Shibin Zhou is a scholar working on Molecular Biology, Oncology and Biotechnology. According to data from OpenAlex, Shibin Zhou has authored 66 papers receiving a total of 14.9k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 23 papers in Oncology and 19 papers in Biotechnology. Recurrent topics in Shibin Zhou's work include Cancer Research and Treatments (19 papers), Monoclonal and Polyclonal Antibodies Research (11 papers) and Virus-based gene therapy research (10 papers). Shibin Zhou is often cited by papers focused on Cancer Research and Treatments (19 papers), Monoclonal and Polyclonal Antibodies Research (11 papers) and Virus-based gene therapy research (10 papers). Shibin Zhou collaborates with scholars based in United States, China and Hong Kong. Shibin Zhou's co-authors include Bert Vogelstein, Kenneth W. Kinzler, Luis A. Díaz, Nickolas Papadopoulos, Victor E. Velculescu, Jian Yu, Tong‐Chuan He, Luís Teixeira da Costa, Leigh Zawel and David Bermudes and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Shibin Zhou

63 papers receiving 14.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cancer Genome Landscapes

2013 5.3k citations Bert Vogelstein, Nickolas Papadopoulos et al. Science profile →
A simplified system for generating recombinant adenoviruses

1998 3.0k citations Shibin Zhou, Jian Yu et al. Proceedings of the National Academy of Sciences profile →
Human Smad3 and Smad4 Are Sequence-Specific Transcription Activators

1998 849 citations Leigh Zawel, Phillip Buckhaults et al. Molecular Cell profile →
Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells

2009 724 citations Jihye Yun, Carlo Rago et al. Science profile →
Tumour-targeting bacteria engineered to fight cancer

2018 608 citations Shibin Zhou, Claudia Gravekamp et al. Nature reviews. Cancer profile →
Eradication of metastatic mouse cancers resistant to immune checkpoint blockade by suppression of myeloid-derived cells

2014 513 citations Andrew D. Skora, Luis A. Díaz et al. Proceedings of the National Academy of Sciences profile →
Cancer therapy with antibodies

2024 102 citations Maximilian F. Konig, Chetan Bettegowda et al. Nature reviews. Cancer profile →

Peers

Shibin Zhou

ONCOL

GENET

IMMUN

Jonathan W. Simons United States

David L. Huso United States

Jos Jonkers Netherlands

Dean W. Felsher United States

Tannishtha Reya United States

Jan Paul Medema Netherlands

Ruggero De Maria Italy

Hideyuki Saya Japan

Gerhard Christofori Switzerland

Owen J. Sansom United Kingdom

Jonathan W. Simons United States

Shibin Zhou

9.4k ×1.1

4.9k ×1.2

ONCOL

6.1k ×1.6

2.8k ×1.3

GENET

2.5k ×1.4

IMMUN

Citations per year, relative to Shibin Zhou Shibin Zhou (= 1×) peers Jonathan W. Simons

Countries citing papers authored by Shibin Zhou

Since Specialization

Citations

This map shows the geographic impact of Shibin Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shibin Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shibin Zhou more than expected).

Fields of papers citing papers by Shibin Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shibin Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shibin Zhou. The network helps show where Shibin Zhou may publish in the future.

Co-authorship network of co-authors of Shibin Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Shibin Zhou. A scholar is included among the top collaborators of Shibin Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shibin Zhou. Shibin Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhou, Shibin, et al.. (2025). The role of ion channels in the regulation of dendritic cell function. Cell Calcium. 128. 103031–103031. 2 indexed citations

Sur, Surojit, Maria Popoli, Shibin Zhou, et al.. (2025). NXPE1 alters the sialoglycome by acetylating sialic acids in the human colon. Nature Communications. 16(1). 4912–4912. 1 indexed citations

Xu, Li, et al.. (2025). Epithelial sodium channel in dendritic cells participates in high-fat-induced inflammatory responses. Molecular Biology Reports. 52(1). 856–856.

Min, Jung-Joon, et al.. (2024). Setting “cold” tumors on fire: Cancer therapy with live tumor-targeting bacteria. Med. 6(1). 100549–100549. 5 indexed citations

Rincón-Torroella, Jordina, Marco Dal Molin, Brian J. Mog, et al.. (2024). ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxylate transporter MCT1. eLife. 13.

Wyhs, Nicolas, Surojit Sur, Maria Popoli, et al.. (2022). An isogenic cell line panel for sequence-based screening of targeted anticancer drugs. iScience. 25(6). 104437–104437. 4 indexed citations

Konig, Maximilian F., Michael Powell, Verena Staedtke, et al.. (2020). Preventing cytokine storm syndrome in COVID-19 using α-1 adrenergic receptor antagonists. Journal of Clinical Investigation. 130(7). 3345–3347. 87 indexed citations

Miller, Michelle S., Jacqueline Douglass, Michael S. Hwang, et al.. (2019). An engineered antibody fragment targeting mutant β-catenin via major histocompatibility complex I neoantigen presentation. Journal of Biological Chemistry. 294(50). 19322–19334. 14 indexed citations

Zhou, Shibin, Claudia Gravekamp, David Bermudes, & Ke Liu. (2018). Tumour-targeting bacteria engineered to fight cancer. Nature reviews. Cancer. 18(12). 727–743. 608 indexed citations breakdown →

10.

Staedtke, Verena, Ren-Yuan Bai, Martin Darvas, et al.. (2018). Disruption of a self-amplifying catecholamine loop reduces cytokine release syndrome. Nature. 564(7735). 273–277. 191 indexed citations

11.

Li, Yuguo, Yuan Qiao, Hanwei Chen, et al.. (2017). Characterization of tumor vascular permeability using natural dextrans and CEST MRI. Magnetic Resonance in Medicine. 79(2). 1001–1009. 35 indexed citations

12.

Chan, Kannie W. Y., Tao Yu, Yuan Qiao, et al.. (2014). A diaCEST MRI approach for monitoring liposomal accumulation in tumors. Journal of Controlled Release. 180. 51–59. 50 indexed citations

13.

Li, Meng, Hong Zhao, Laura D. Wood, et al.. (2011). Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma. Nature Genetics. 43(9). 828–829. 302 indexed citations

14.

Yun, Jihye, Carlo Rago, Ian Cheong, et al.. (2009). Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells. Science. 325(5947). 1555–1559. 724 indexed citations breakdown →

15.

Cheong, Ian & Shibin Zhou. (2009). Chapter 13 Tumor-Specific Liposomal Drug Release Mediated by Liposomase. Methods in enzymology on CD-ROM/Methods in enzymology. 465. 251–265. 13 indexed citations

16.

Cheong, Ian, Xin Huang, Chetan Bettegowda, et al.. (2006). A Bacterial Protein Enhances the Release and Efficacy of Liposomal Cancer Drugs. Science. 314(5803). 1308–1311. 136 indexed citations

17.

Bettegowda, Chetan, Xin Huang, Jimmy Lin, et al.. (2006). The genome and transcriptomes of the anti-tumor agent Clostridium novyi-NT. Nature Biotechnology. 24(12). 1573–1580. 126 indexed citations

18.

Zawel, Leigh, Jian Yu, C Torrance, et al.. (2002). DEC1 is a downstream target of TGF-β with sequence-specific transcriptional repressor activities. Proceedings of the National Academy of Sciences. 99(5). 2848–2853. 81 indexed citations

19.

Zhou, Shibin, Leigh Zawel, Christoph Lengauer, K. W. Kinzler, & Bert Vogelstein. (1998). Characterization of Human FAST-1, a TGFβ and Activin Signal Transducer. Molecular Cell. 2(1). 121–127. 208 indexed citations

20.

Sousa, Rui, Nancy Hrinya Tannery, Shibin Zhou, & Eileen M. Lafer. (1992). Characterization of a novel synapse-specific protein. I. Developmental expression and cellular localization of the F1-20 protein and mRNA. Journal of Neuroscience. 12(6). 2130–2143. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact